Active Ingredient: Lanreotide
Treatment Areas: Acromegaly, Carcinoid Tumors
Form: Syringe | 60 mg / 0.5 ml, 90 mg / 0.5 ml, 120 mg / 0.5 ml
Licensor: Ipsen